Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1184664.RAWFlkH0TFcY0W7fv409Zv7-xGPdAW3tM0VI_iJxoo1pw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1184664.RAWFlkH0TFcY0W7fv409Zv7-xGPdAW3tM0VI_iJxoo1pw130_assertion type Assertion NP1184664.RAWFlkH0TFcY0W7fv409Zv7-xGPdAW3tM0VI_iJxoo1pw130_head.
- NP1184664.RAWFlkH0TFcY0W7fv409Zv7-xGPdAW3tM0VI_iJxoo1pw130_assertion description "[M2PK showed a detection rate of 40.3% for adenomas but the combination of M2PK and KRAS abnormalities was found in only 5.7% of adenomas (P <0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1184664.RAWFlkH0TFcY0W7fv409Zv7-xGPdAW3tM0VI_iJxoo1pw130_provenance.
- NP1184664.RAWFlkH0TFcY0W7fv409Zv7-xGPdAW3tM0VI_iJxoo1pw130_assertion evidence source_evidence_literature NP1184664.RAWFlkH0TFcY0W7fv409Zv7-xGPdAW3tM0VI_iJxoo1pw130_provenance.
- NP1184664.RAWFlkH0TFcY0W7fv409Zv7-xGPdAW3tM0VI_iJxoo1pw130_assertion SIO_000772 24852854 NP1184664.RAWFlkH0TFcY0W7fv409Zv7-xGPdAW3tM0VI_iJxoo1pw130_provenance.
- NP1184664.RAWFlkH0TFcY0W7fv409Zv7-xGPdAW3tM0VI_iJxoo1pw130_assertion wasDerivedFrom befree-2016 NP1184664.RAWFlkH0TFcY0W7fv409Zv7-xGPdAW3tM0VI_iJxoo1pw130_provenance.
- NP1184664.RAWFlkH0TFcY0W7fv409Zv7-xGPdAW3tM0VI_iJxoo1pw130_assertion wasGeneratedBy ECO_0000203 NP1184664.RAWFlkH0TFcY0W7fv409Zv7-xGPdAW3tM0VI_iJxoo1pw130_provenance.